内镜医师与中心内镜逆行胰胆管造影术操作量与手术成功及不良结局的关联:系统综述与荟萃分析
该系统综述与荟萃分析检索MEDLINE、EMBASE和Cochrane对照试验中心注册库至2017年1月,纳入13篇文章共59437例内镜逆行胰胆管造影术(ERCP)。高操作量内镜医师和中心的手术成功几率更高,高操作量内镜医师术后不良事件风险更低,高操作量中心的不良事件风险无显著差异。作者建议提供者与支付方考虑将ERCP集中至高操作量内镜医师。
要点
- 高操作量内镜医师较低操作量者更可能实现ERCP成功(OR=1.6,95%CI 1.2-2.1)。
- 高操作量中心较低操作量中心更可能实现ERCP成功(OR=2,95%CI 1.6-2.5)。
- 高操作量内镜医师术后不良事件风险较低(OR=0.7,95%CI 0.5-0.8),高操作量中心无显著差异(OR=0.7,95%CI 0.3-1.5)。
核心结论
- 内镜医师和中心ERCP操作量增加与总体手术成功存在显著关联,内镜医师操作量增加还与不良事件率降低相关。
- 作者提出,提供者与支付方应考虑将ERCP集中至高操作量内镜医师,以改善ERCP结局与价值。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE和Cochrane对照试验中心注册库,检索时间自建库至2017年1月。
- 最终纳入13篇文章,共59437例ERCP,纳入按内镜医师和/或中心操作量分层报告结局的研究。
- 内镜医师/中心操作量分为低操作量(LV)和高操作量(HV),各研究间定义不同。
主要发现
- 文献检索共获得1264条引文,其中13篇文章(n=59437例ERCP)符合纳入标准。
- 低操作量内镜医师定义为年ERCP量<25至<156例,低操作量中心定义为年ERCP量<87至<200例,各研究间定义不同。
- 高操作量内镜医师较低操作量内镜医师更可能实现ERCP成功(OR=1.6,95%CI 1.2-2.1)。
- 高操作量中心较低操作量中心更可能实现ERCP成功(OR=2,95%CI 1.6-2.5)。
- 高操作量内镜医师的ERCP术后不良事件风险较低(OR=0.7,95%CI 0.5-0.8),高操作量中心无显著差异(OR=0.7,95%CI 0.3-1.5)。
关键数值与推荐
- ERCP成功的定义在各研究间不同。
- 总体不良事件率为包含胰腺炎、穿孔和出血的复合率。
- 低操作量内镜医师定义为年ERCP量<25至<156例,低操作量中心定义为年ERCP量<87至<200例。
临床怎么用
- 作者提出,提供者与支付方应考虑将ERCP集中至高操作量内镜医师,以改善ERCP结局与价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Endoscopic retrograde cholangiopancreatography (ERCP) has become a predominantly therapeutic intervention with a resultant increase in complexity. The relationship between ERCP volume and outcomes is unclear. We aimed to conduct a systematic review and meta-analysis assessing the relationship between endoscopist and center ERCP volume with ERCP success and adverse event (AE) rates. METHODS: A comprehensive search of MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials was conducted from inception to January 2017. Studies providing outcomes stratified by endoscopist and/or center volume were included in the final analysis. Endoscopist/center volume was stratified as low volume (LV) and high volume (HV). The definition of ERCP success varied between studies. The overall AE rate was a composite rate including pancreatitis, perforation, and bleeding. RESULTS: A literature search resulted in 1264 citations. Of those, 13 articles (n = 59,437 ERCPs) met inclusion criteria. LV endoscopist (<25 to <156 annual ERCPs) and center (<87 to <200 annual ERCPs) definitions varied between studies. HV endoscopists were significantly more likely to achieve ERCP success compared with LV endoscopists (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.2-2.1). HV centers were significantly more likely to achieve ERCP success (OR, 2; 95% CI, 1.6-2.5). The post-ERCP AE risk was lower for HV endoscopists (OR, 0.7; 95% CI, 0.5-0.8) but not HV centers (OR, 0.7; 95% CI, 0.3-1.5). CONCLUSIONS: This study identifies a significant relationship between increasing endoscopist and center ERCP volume with overall procedure success. Increasing endoscopist volume also was associated with a decreased AE rate. Given these compelling findings, we propose that providers and payers consider consolidating ERCP to HV endoscopists to improve ERCP outcomes and value.
引用
- Keswani RN, Qumseya BJ, O'Dwyer LC, et al. Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017. PMID: 28606848. doi:10.1016/j.cgh.2017.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。